Advertisement
Research Article| Volume 1, ISSUE 3, P541-545, September 1981

Tricyclic Antidepressants and Lithium

  • James M. Byers III
    Correspondence
    Corresponding author: Department of Pathology, University of Arizona Health Sciences Center, Tucson, Arizona 85724
    Affiliations
    Associate Professor of Pathology, University of Arizona; Chief, Toxicology Section, University Hospital Clinical Laboratories, Tucson, Arizona
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)31089-8
Tricyclic Antidepressants and Lithium
Previous ArticleDigitalis and Vasoactive Drugs
Next ArticlePhenothiazines
      This paper is only available as a PDF. To read, Please Download here.
      Although difficulty in correlating plasma levels of tricyclic antidepressants with therapeutic outcome has been reported, therapeutic monitoring can be helpful in the management of selected depressed patients. The greater toxic potential of lithium is a pressing and clear indication for therapeutic monitoring in manic patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Abramowicz M.
        Drugs for depression.
        Med. Lett. 1978; 20: 49
        • Abramowicz M.
        Lithium for cluster headache.
        Med. Lett. 1979; 21: 78
        • Abramowicz M.
        Another look at lithium.
        Med. Lett. 1980; 22: 17
        • Ananth J.
        • Engelsmann F.
        • Kiriakus R.
        Evaluation of lithium response: Psychometric findings.
        Can. J. Psychiatry. 1980; 25: 151
        • Baldessarini R.J.
        Chemotherapy in Psychiatry.
        Harvard University Press, Cambridge1977: 57-125
        • Biggs J.T.
        Clinical pharmacology and toxicology of antidepressants.
        Hosp. Pract. 1978; 13: 79
        • Burckhardt D.
        • Raeder E.
        • Mueller V.
        • et al.
        Cardiovascular effects of tricyclic and tetracyclic antidepressants.
        J.A.M.A. 1978; 239: 213
        • Coppen A.
        • Ghose K.
        • Montgomery S.
        • et al.
        Amitriptyline plasma, concentration and clinical effect.
        Lancet. 1978; 1: 63
        • Gram L.F.
        Plasma level monitoring of tricyclic antidepressant therapy.
        Clin. Pharmacokinet. 1977; 2: 237
        • Gugler R.
        • Azarnoff D.L.
        The clinical use of plasma drug concentrations.
        Ration. Drug Ther. 1976; 10: 1
        • Hollister L.E.
        Monitoring tricyclic antidepressant plasma concentrations.
        J.A.M.A. 1979; 241: 2530
        • Jatlow P.
        Therapeutic monitoring of plasma concentrations of tricyclic antidepressants.
        Arch. Pathol. Lab. Med. 1980; 104: 341
        • Jorgensen O.S.
        • et al.
        Plasma concentrations and clinical effect in imipramine treatment of childhood enuresis.
        Clin. Pharmacokinet. 1980; 5: 386
        • Klerman G.L.
        • Hirshfeld M.A.
        The use of antidepressants in clinical practice.
        J.A.M.A. 1978; 240: 1403

      15. Lieberman, J. A., and O’Connell, R. A.: Clinical utility of tricyclic blood levels. N.Y. State J. Med., p. 1967, December 1980.

        • Mason A.S.
        • Granacher R.P.
        Clinical Handbook of Antipsychotic Drug Therapy.
        Brunner/Mazel, Publishers, New York1980: 255-286
        • Orsulak P.J.
        • Schildkraut J.J.
        Guidelines for therapeutic monitoring of tricyclic antidepressant plasma levels.
        Ther. Drug Monitor. 1979; 1: 199
        • Scoggins B.A.
        • Maguire K.P.
        • Norman T.R.
        • et al.
        Measurement of tricyclic antidepressants. Part 1. A review of methodology.
        Clin. Chem. 1980; 26: 5
        • Sjoeqvist F.
        Clinical use of drug plasma level determinations.
        in: Azarnoff D.L. Year Book of Drug Therapy. Year Book Medical Publishers, Chicago1977: 13
        • Ziegler V.E.
        • Biggs J.T.
        Tricyclic plasma levels: Effect of age, race, sex, and smoking.
        J.A.M.A. 1977; 238: 2167

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)31089-8

      Copyright

      © 1981 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX